Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Temporal trends in homocysteine level measurements at a tertiary cardiovascular center in the years 2016-2024: prevalence of hyperhomocysteinemia and homocystinuria.

Polish archives of internal medicine·2025

Same author

Newly diagnosed homocystinuria as a rare cause of advanced peripheral artery disease in a 41-year-old man.

Polish archives of internal medicine·2025

Same author

Palliative Care for Children and Adults With Inherited Metabolic Disease in Europe: An Underutilised Service for Supportive Treatment and Care.

Journal of inherited metabolic disease·2025

Same author

Home Enzyme Replacement Therapy in Gaucher Disease: A Review.

Journal of clinical medicine·2025

Same author

Thyroid Function and Morphology in Gaucher Disease: Exploring the Endocrine Implications.

International journal of molecular sciences·2025

Same author

Diagnosis and treatment of Fabry disease. Expert Opinion of the Polish Cardiac Society and the Polish Forum for Fabry Disease.

Kardiologia polska·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Extraction and Analysis of Taiwanese Green Propolis

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

Antioxidant phytochemicals against type 2 diabetes.

Aldona Dembinska-Kiec¹, Otto Mykkänen, Beata Kiec-Wilk

¹Department of Clinical Biochemistry, The Jagiellonian University Collegium Medicum, Kopernika 15a, Kraków 31-501, Poland. mbkiec@cyf-kr.edu.pl

The British Journal of Nutrition

|June 25, 2008

Summary

Dietary phytochemicals, particularly polyphenols found in plant-based foods, can help manage lipid and glucose levels. This may reduce the risk of metabolic syndrome and complications from type 2 diabetes.

Related Experiment Videos

Last Updated: Jul 5, 2026

Extraction and Analysis of Taiwanese Green Propolis

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

Area of Science:

Nutritional Science
Biochemistry
Metabolic Health

Background:

Obesity-associated chronic diseases, including type 2 diabetes, pose significant health risks.
Dietary phytochemicals, a diverse group of plant compounds, are increasingly recognized for their potential health benefits.
Polyphenols represent a major class of phytochemicals with antioxidant and anti-inflammatory properties.

Purpose of the Study:

To provide an overview of how dietary phytochemicals, specifically polyphenols, can influence metabolic homeostasis.
To explore the role of these compounds in mitigating risks associated with obesity and metabolic syndrome.
To examine the potential of phytochemicals in preventing type 2 diabetes complications.

Main Methods:

Literature review and synthesis of existing research on phytochemicals and metabolic health.
Analysis of studies focusing on polyphenols from various dietary sources (fruits, vegetables, berries, beverages, herbal medicines).
Examination of mechanisms by which phytochemicals affect lipid and glucose metabolism.

Main Results:

Phytochemicals, especially polyphenols, demonstrate the capacity to modulate imbalanced lipid and glucose homeostasis.
Evidence suggests these compounds can improve insulin sensitivity and lipid profiles.
Specific phytochemicals show potential in reducing inflammation and oxidative stress linked to metabolic dysfunction.

Conclusions:

Dietary intake of phytochemicals, rich in polyphenols, offers a promising strategy for managing metabolic health.
These compounds may play a crucial role in reducing the risk and complications of type 2 diabetes and metabolic syndrome.
Further research into specific phytochemicals and their synergistic effects is warranted for therapeutic applications.